Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
COMPANY PERFORMANCE<br />
Your company has recorded yet another year <strong>of</strong> good performance<br />
during the year under review. The total revenue at Rs.1184.48<br />
million for the year ended March 2006 as against Rs.783.75 million<br />
for the same period during the previous year higher by 51% and pr<strong>of</strong>it<br />
at Rs.350.62 million as <strong>of</strong> March 2006 as against Rs.190.43 million<br />
for the same period during the previous year million represents as<br />
increase <strong>of</strong> 84% over the previous year.<br />
DIVIDEND<br />
Considering the performance <strong>of</strong> the Company, your <strong>Directors</strong>' are<br />
pleased to recommend an Dividend at the rate <strong>of</strong> 40% for the year<br />
ended 31st March 2006 on the equity share capital, which amounts<br />
Rs.4.00 per share.<br />
MANAGEMENT DISCUSSION AND ANALYSIS<br />
Executive Summary<br />
Your Company is engaged in the Design, Development,<br />
Manufacturing, Marketing and Distribution <strong>of</strong> Medical Electronic<br />
Devices and Medical monitoring products employing Sensing and<br />
Detection techniques. In the past fourteen years the company has<br />
established itself as a leading supplier <strong>of</strong> noninvasive OEM Optical<br />
sensors in the field <strong>of</strong> Patient monitoring systems.<br />
The company has received US FDA approval for its SpO2 products. It<br />
has also added two new products to its patient monitoring range.<br />
32<br />
DIRECTORS REPORT<br />
st<br />
Your <strong>Directors</strong> have pleasure in presenting their report on the business and operations <strong>of</strong> the company for the year ended 31 March 2006<br />
Financial Results Year Ended<br />
(Rs.in millions)<br />
Year Ended<br />
31.03.06 31.03.05<br />
Total Revenue 1184.48 783.75<br />
Pr<strong>of</strong>it before Depreciation 363.94 207.02<br />
Depreciation 12.35 12.88<br />
Pr<strong>of</strong>it before Tax 351.59 194.14<br />
Provision for taxation 1.32 2.50<br />
Prior year adjustments 0.34 (1.20)<br />
Pr<strong>of</strong>it for the year 350.62 190.43<br />
APPROPRIATION<br />
Proposed Dividend 123.23 62.55<br />
Tax on Dividend 17. 28 8.17<br />
Surplus carried to Balance Sheet 210.11 119.71<br />
The company is also expanding into new geographical territory with<br />
<strong>of</strong>fices established in Dubai and Germany. Our world wide<br />
distribution network helps market our products globally.<br />
COMPANY OVERVIEW<br />
The group comprises <strong>Opto</strong> <strong>Circuits</strong> India Ltd, a public listed<br />
company and Advanced Micronic Devices Limited, also a listed<br />
company and Medi Aid Inc, USA. <strong>Opto</strong> <strong>Circuits</strong> India Ltd has been<br />
steadily growing at an annual rate <strong>of</strong> approximately 36% and is a<br />
leader in Medical Non-Invasive sensors. The combined revenues <strong>of</strong><br />
<strong>Opto</strong> and Advanced Micronic Devices Ltd, is Rs.1454.49 million (US<br />
$ 32.40) million.<br />
During the year your company also has acquired Eurocor Gmbh,<br />
which is in the business <strong>of</strong> manufacturing Cardiac and Peripheral<br />
stents with a market size <strong>of</strong> 10 Billion USD which is growing at the<br />
rate <strong>of</strong> 15% annually.<br />
After the acquisition Eurocor received the CE approval for its Taxcor<br />
Drug Eluting Stents. The company has also acquired a 100% stake in<br />
Altron Industries during 2004-05 which is engaged in providing<br />
Electronic manufacturing services at its state <strong>of</strong> art manufacturing<br />
facility at Electronic City, Bangalore.<br />
During the current year, your company also had a very successful<br />
follow on Public <strong>of</strong>fering <strong>of</strong> 4 million shares at a price <strong>of</strong> Rs.270 per